Independent prognostic role of p16 expression in lung cancer
- 1 September 1999
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 118 (3) , 529-535
- https://doi.org/10.1016/s0022-5223(99)70192-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- p21waf1/cip1mda-6 Expression in Non-small-cell Lung Cancer: Relationship to SurvivalAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancerGenes, Chromosomes and Cancer, 1997
- Frequent mutations of CDKN2 in primary pancreatic adenocarcinomasGenes, Chromosomes and Cancer, 1995
- Alterations of CDKN2 (p16) in non‐small cell lung cancerGenes, Chromosomes and Cancer, 1995
- Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancerBritish Journal of Cancer, 1995
- Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.The EMBO Journal, 1995
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993